
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epigenetic regulation in lung cancer
Shahin Ramazi, Maedeh Dadzadi, Zahra Sahafnejad, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 26
Shahin Ramazi, Maedeh Dadzadi, Zahra Sahafnejad, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Methylation Biomarkers of Lung Cancer Risk: A Systematic Review and Meta-Analysis
Jacopo Dolcini, Manuela Chiavarini, Giorgio Firmani, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 690-690
Open Access | Times Cited: 1
Jacopo Dolcini, Manuela Chiavarini, Giorgio Firmani, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 690-690
Open Access | Times Cited: 1
The multipotential effect of microbiome in lung cancer development and progression
Nastaran Karimi, Angélica Baca De Anda, Rachel Yang, et al.
International review of cell and molecular biology (2025)
Closed Access
Nastaran Karimi, Angélica Baca De Anda, Rachel Yang, et al.
International review of cell and molecular biology (2025)
Closed Access
Epigenomic Echoes—Decoding Genomic and Epigenetic Instability to Distinguish Lung Cancer Types and Predict Relapse
Anke Baumann, Zholdas Buribayev, Olaf Wolkenhauer, et al.
Epigenomes (2025) Vol. 9, Iss. 1, pp. 5-5
Open Access
Anke Baumann, Zholdas Buribayev, Olaf Wolkenhauer, et al.
Epigenomes (2025) Vol. 9, Iss. 1, pp. 5-5
Open Access
Epigenetic modifications in early stage lung cancer: pathogenesis, biomarkers, and early diagnosis
Lingfeng Bi, Xin Wang, Jiayi Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Lingfeng Bi, Xin Wang, Jiayi Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Personalized Approaches to Lung Cancer Treatment: A Review of Targeted Therapies, Pharmacogenomics, and Combination Strategies
M. Tabrizi Namini, G. Bhagya, Manjari Sharma
Aspects of Molecular Medicine (2025), pp. 100073-100073
Open Access
M. Tabrizi Namini, G. Bhagya, Manjari Sharma
Aspects of Molecular Medicine (2025), pp. 100073-100073
Open Access
Tumor Heterogeneity and the Immune Response in Non-Small Cell Lung Cancer: Emerging Insights and Implications for Immunotherapy
Michael S. Oh, Jensen Abascal, Austin K. Rennels, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 1027-1027
Open Access
Michael S. Oh, Jensen Abascal, Austin K. Rennels, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 1027-1027
Open Access
DNA methylation heterogeneity correlates with field cancerization and prognosis in lung adenocarcinoma patients
Ying Zhou, Jing Zhang, Yang He, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
Ying Zhou, Jing Zhang, Yang He, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
Protein modification in neurodegenerative diseases
Shahin Ramazi, Maedeh Dadzadi, Mona Darvazi, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 4
Shahin Ramazi, Maedeh Dadzadi, Mona Darvazi, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 4
Fabrication of etoposide-loaded folic-acid-clocked mesoporous nanoparticles: Investigation of lung cancer proliferation and induction of apoptosis and ferroptosis
Wanwan Chen, Xuezhen Cao, Songsong Wu, et al.
Process Biochemistry (2024) Vol. 141, pp. 19-29
Closed Access | Times Cited: 3
Wanwan Chen, Xuezhen Cao, Songsong Wu, et al.
Process Biochemistry (2024) Vol. 141, pp. 19-29
Closed Access | Times Cited: 3
The upregulation and transcriptional regulatory mechanisms of Extra spindle pole bodies like 1 in bladder cancer: An immunohistochemistry and high-throughput screening Evaluation
Wei Zhang, Zi-Qian Liang, Rong‐Quan He, et al.
Heliyon (2024) Vol. 10, Iss. 10, pp. e31192-e31192
Open Access | Times Cited: 3
Wei Zhang, Zi-Qian Liang, Rong‐Quan He, et al.
Heliyon (2024) Vol. 10, Iss. 10, pp. e31192-e31192
Open Access | Times Cited: 3
Targeting piRNA‐137463 Inhibits Tumor Progression and Boosts Sensitivity to Immune Checkpoint Blockade via De Novo Cholesterol Biosynthesis in Lung Adenocarcinoma
Yuning Zhan, Fanglin Tian, Weina Fan, et al.
Advanced Science (2024)
Open Access | Times Cited: 3
Yuning Zhan, Fanglin Tian, Weina Fan, et al.
Advanced Science (2024)
Open Access | Times Cited: 3
Targeting RET alterations in non-small cell lung cancer
Go Nishikawa, Mark Klein
Current Problems in Cancer (2024) Vol. 49, pp. 101074-101074
Closed Access | Times Cited: 2
Go Nishikawa, Mark Klein
Current Problems in Cancer (2024) Vol. 49, pp. 101074-101074
Closed Access | Times Cited: 2
Epigenetic modulation of cytokine expression in Mycobacterium tuberculosis-infected monocyte derived-dendritic cells: Implications for tuberculosis diagnosis
Maryam Meskini, Mohammad Saber Zamani, Amir Amanzadeh, et al.
Cytokine (2024) Vol. 181, pp. 156693-156693
Closed Access | Times Cited: 2
Maryam Meskini, Mohammad Saber Zamani, Amir Amanzadeh, et al.
Cytokine (2024) Vol. 181, pp. 156693-156693
Closed Access | Times Cited: 2
Sensitive detection of miR-9 in human serum: An electrochemical approach utilizing robust gold nanostructures for early diagnosis of lung cancer
Zahra Sahafnejad, Hadi Hashemzadeh, Abdollah Allahverdi, et al.
Talanta Open (2023) Vol. 8, pp. 100272-100272
Open Access | Times Cited: 6
Zahra Sahafnejad, Hadi Hashemzadeh, Abdollah Allahverdi, et al.
Talanta Open (2023) Vol. 8, pp. 100272-100272
Open Access | Times Cited: 6
Machine learning-based approaches for ubiquitination site prediction in human proteins
Mahdi Pourmirzaei, Shahin Ramazi, Farzaneh Esmaili, et al.
BMC Bioinformatics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Mahdi Pourmirzaei, Shahin Ramazi, Farzaneh Esmaili, et al.
BMC Bioinformatics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Two Sides of the Same Coin: Genes Involved in Neurodegeneration and Cancer
Martina Montanari, Maria Meringolo, Ilham El Atiallah, et al.
(2024)
Open Access | Times Cited: 1
Martina Montanari, Maria Meringolo, Ilham El Atiallah, et al.
(2024)
Open Access | Times Cited: 1
Tumor‐associated exosomes in cancer progression and therapeutic targets
Xiaomin Liu, Fan Wu, Wei Pan, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 1
Xiaomin Liu, Fan Wu, Wei Pan, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 1
A combined model of circulating tumor DNA methylated SHOX2/SCT/HOXA7 and clinical features facilitates the discrimination of malignant from benign pulmonary nodules
Lu He, Biao Zhang, Chu Zhou, et al.
Lung Cancer (2024) Vol. 199, pp. 108064-108064
Closed Access | Times Cited: 1
Lu He, Biao Zhang, Chu Zhou, et al.
Lung Cancer (2024) Vol. 199, pp. 108064-108064
Closed Access | Times Cited: 1
Decoding the complex web: Cellular and molecular interactions in the lung tumor microenvironment
Bonnie Issa, Ayat Hussein Adhab, Morug Salih Mahdi, et al.
Journal of drug targeting (2024), pp. 1-44
Closed Access | Times Cited: 1
Bonnie Issa, Ayat Hussein Adhab, Morug Salih Mahdi, et al.
Journal of drug targeting (2024), pp. 1-44
Closed Access | Times Cited: 1
Two Sides of the Same Coin: Genes Involved in Neurodegeneration and Cancer
Martina Montanari, Maria Meringolo, Ilham El Atiallah, et al.
Interdisciplinary cancer research (2024)
Closed Access
Martina Montanari, Maria Meringolo, Ilham El Atiallah, et al.
Interdisciplinary cancer research (2024)
Closed Access
SFRP4 protein expression is reduced in high grade astrocytomas which is not caused by the methylation of its promoter
Anja Kafka, Nives Pećina‐Šlaus, Denis Drmić, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access
Anja Kafka, Nives Pećina‐Šlaus, Denis Drmić, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access
Histone modification and personalized epigenomics in cancer
Shahin Ramazi, Maedeh Dadzadi, Zahra Sahafnejad, et al.
Elsevier eBooks (2024), pp. 429-473
Closed Access
Shahin Ramazi, Maedeh Dadzadi, Zahra Sahafnejad, et al.
Elsevier eBooks (2024), pp. 429-473
Closed Access
DNA Methylation Analysis Identifies Clinically Relevant Lung Adenocarcinoma Subgroups
Oluwadamilare I. Afolabi
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Oluwadamilare I. Afolabi
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity
Raluca Munteanu, Cristian Moldovan, Adrian Bogdan Țigu, et al.
Medicine and Pharmacy Reports (2024) Vol. 97, Iss. 4, pp. 488-506
Open Access
Raluca Munteanu, Cristian Moldovan, Adrian Bogdan Țigu, et al.
Medicine and Pharmacy Reports (2024) Vol. 97, Iss. 4, pp. 488-506
Open Access